Libtayo for Squamous Cell Carcinoma User Reviews
Libtayo has an average rating of 7.8 out of 10 from a total of 4 reviews for the treatment of Squamous Cell Carcinoma. 75% of reviewers reported a positive experience, while 25% reported a negative experience.
- Itisw...
- Taken for 6 months to 1 year
- February 2, 2023
"Overall I felt good, except for the terrible itching that started on my back , then my sides, then my legs , then my head. I tried everything the Dr prescribed and a dozen creams and powders, they only work temporarily a hour or so. Then my itching has turned into several sores, large rash like and painful, I wish I knew what would help me with this.I want to keep the treatment going as it's working on my CSCC and NSCLC. I have been on therapy for 8 months. I have 4 months to go. Pray for me. Thank you"
- Pat...
- Taken for less than 1 month
- May 16, 2023
"Had one treatment, and after 3 days I got a headache, diarrhea, rash, chills, felt weak, and ended up in the hospital for 3 days. I am now on prednisone to combat the rash and it has been 2 weeks and has not improved. Got off of Libtayo because of severe side effects. Now have to seek further treatment for side effects. Cancer has moved to the back burner. Very frustrating."
Frequently asked questions
- Paul
- Taken for 1 to 6 months
- October 8, 2019
"It caused skin problems, fatigue and shortness of breath."
- Lotta...
- Taken for 1 to 6 months
- September 22, 2019
"Severe eczema on my legs, arms and back, along with itchy skin, feels like ants crawling all over my body for the first 3-4 weeks"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Libtayo (cemiplimab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"I'm alive today because of Libtayo. It truly has been a wonder drug for me. It brought me back from death's door when I was in hospice with leptomigineal disease from squamous cell carcinoma. My cancer was virtually eliminated at the time. Two years later, I am practicing law again, living life and loving every minute. I'm back on Libtayo as the cancer has flared up in my spine, but I have no side effects except some moderate fatigue. I'm sorry for people who get skin rashes and other problems, but my experience is wonderful. I was the first Mayo Jacksonville patient to receive the drug (right after FDA approval), and it has far surpassed its expectations. The nurses and doctors here speak of the drug very highly."